Pregnancy outcome after treatment for Wilms tumor: A report from the National Wilms Tumor Study Group

Journal of Clinical Oncology

Volumn 20, Issue 10, 2002, Pages 2506-2513

  Green, Daniel M ^a   Peabody, Eve M ^a   Nan, Bin ^a   Peterson, Susan ^a   Kalapurakal, John A ^a   Breslow, Norman E ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONGENITAL MALFORMATION; DOSE RESPONSE; FEMALE; GESTATIONAL AGE; HIGH RISK POPULATION; HUMAN; IMMINENT ABORTION; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MALPRESENTATION; MEDICAL RECORD; NEPHROBLASTOMA; NEWBORN; PREGNANCY COMPLICATION; PREMATURITY; PRIORITY JOURNAL; PROGENY; RADIATION DOSE; TERATOGENICITY;

ABDOMEN; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; KIDNEY NEOPLASMS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SEX FACTORS; WILMS TUMOR;

EID: 0037093084     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.07.159     Document Type: Article

References (55)

1. Cancer incidence, survival and mortality for children younger than 15 years of age
2. The impact of childhood cancer on the United States and the world
3. Treatment of Wilms' tumor: Results of the Third National Wilms' Tumor Study
4. The treatment of Wilm's tumor
5. The treatment of Wilms' tumor: Results of the second national Wilms' tumor study
6. A comparison between single dose and divided dose administration of dactinomycin and doxorubicin: A report from the National Wilms Tumor Study Group
7. The effect of duration of treatment on outcome and cost of the treatment for Wilms tumor: A report from the National Wilms Tumor Study Group
8. Offspring of patients treated for unilateral Wilms' tumor in childhood
9. Reproductive problems and birth defects in survivors of Wilms' tumor and their relatives
10. Outcome of pregnancy in survivors of Wilms' tumor
11. Pregnancy outcomes in childhood cancer survivors: Probable effects of abdominal irradiation
12. Pregnancy outcome after therapy of childhood cancer
13. Offspring of patients treated for cancer in childhood
14. Childhood cancer survivors and their offspring studied through a postal survey of general practitioners: Preliminary results
15. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer
16. Congenital anomalies in children of patients who received chemotherapy for cancer in childhood and adolescence
17. Birth defects and childhood cancer in offspring of survivors of childhood cancer
18. Radiation therapy in the management of children with gynecologic cancers
19. The regression analysis of binary sequences
20. Heritability of Wilms' tumor
21. Accuracy of spontaneous abortion recall
22. Incidence of early loss of pregnancy
23. Abortion surveillance: United States, 1997
24. Trends in pregnancies and pregnancy rates by outcome: Estimates for the United Sates, 1976-1996
25. Diastolic hypertension in Wilms' tumor: A late effect of treatment? A report from the National Wilms' Tumor Study Group
26. Renal failure in Wilms tumor patients: A report from the National Wilms Tumor Study Group
27. Management of pregnancy induced hypertension
28. Pre-eclampsia and kidney disease
29. Salt in pregnancy
30. Some observations on the incidence of preeclampsia
31. Perinatal mortality in Hong Kong and in Aberdeen, Scotland
32. Births: Final data for 1999
33. Malpresentations and umbilical cord complications
34. The umbilical cord complications of true knots, nuchal cords, and cords around the body
35. Pregnancy outcomes in females after treatment for childhood cancer
36. Abdominal irradiation in childhood: The potential for pregnancy
37. Factors of importance for implantation and problems after treatment for childhood cancer
38. Risk of childhood cancer for infants with birth defects: A record linkage study. Atlanta, Georgia, 1968- 1988
39. Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors
40. Search for mutations altering protein charge and/or function in children of atomic bomb survivors: Final report
41. Search for mutations affecting protein structure in children of atomic bomb survivors: Preliminary report
42. Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivor
43. Detection of somatic mutations at the glycophorin A locus in erythrocytes of atomic bomb survivors using a single beam flow cytometer
44. Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: A comparative study of assay methods
45. Somatic cell mutations in atomic bomb survivors
46. Increased somatic cell mutant frequency in atomic bomb survivors
47. Somatic gene mutations in vivo as indicated by the 6-thioguanine-resistant T-lymphocytes in human blood
48. Factors influencing mutation at the hprt locus in T-lymphocytes: Women treated for breast cancer
49. Multiple biological markers in germ cell tumors patients treated with platinum-based chemotherapy
50. Do mutations at the glycophorin A locus in patients treated for childhood Hodgkin's disease predict secondary leukaemia
51. The assessment of in vivo somatic mutations in survivors of childhood malignancy
52. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: Comparison with HPRT locus mutation